Aphria Inc. Becomes a Contender in This Serious MJ market https://www.fool.ca/2018/04/25/aphria-inc-becomes-a-contender-in-this-serious-marijuana-growth-market/
The above article was dated April 25, 2018 but it elaborates how Nuuvera, CC Pharma GmbH, and Aphria can leverage each other's strengths very nicely.
I *speculate* that the timing of the deal could hint that the LP license in Germany is coming very soon !!
"
the company’s inroads into the exponentially growing E.U. market could be a good thing for the company’s stock.
Nuuvera Corp. (renamed to Aphria International Inc.), Aphria now has access to more than 13,000 distribution pharmacies in Germany, one of the fastest-growing medical cannabis market.
The company is now able to compete for the growing cannabis market pie in a strategically important market place, and on a better footing, with a bigger potential “sales force.” Aphria International signed distribution agreements with CC Pharma GmbH in January this year, and had entered a 77,000-kgs-per-annum offtake agreement with its parent company for international cannabis supplies.
the Nuuvera acquisition also brought into the company the ownership of an E.U. GMP (European Union Good Manufacturing Practices) certified factory located in Malta and a Canadian GMP-certified factory, named the Avanti, which the company is proud to label as “the only Canadian cannabis GMP-certified lab,” which could enable the company to process cannabis products under a GMP licence for export internationally. GMP licensing is a critical and hard-to-obtain requirement for any pharmaceuticals exports into Europe, without which no medical marijuana may be exported to the continent.
Furthermore, Nuuvera was one of the very few shortlisted bidders for local cannabis production licences in Germany — a territory that has allowed medical marijuana patients to enjoy full insurance cover for their prescriptions, allowing the market to grow at a higher rate. If awarded, such a licence could be a huge growth asset.
"